🇮🇳 India Stock Screener ← Switch market ⚡ HerAI

Albert David Limited ALBERTDAVD NSEPHARMA

Healthcare · Drug Manufacturers - Specialty & Generic · India
https://www.albertdavidindia.com
Company Profile ↓
₹784.30
-1.35% 1Y
Mkt Cap₹447.61 Cr
P/E19.84
P/B1.15
Div. Yield0.62%
52W High₹898.60
52W Low₹582.79
Book Value₹686.04
EPS (TTM)₹39.53

Company Overview

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, and vision care products. The company exports its products to Latin American, South East Asian and North African countries Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

Why Investors Should Care

Reasonable Valuation

Trades at a P/E of 19.8, below the sector median of 35.9.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.08.

Recent Developments

  • Mar 2026 Revenue of ₹329.36 Cr (-4.0% YoY); net profit ₹-1.49 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +43.6%, earnings +303.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR -1.1%, profit CAGR -34.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-1.05%
1 Year:43.60%

Compounded Profit Growth

5 Years:-34.71%
1 Year:303.10%

Stock Price Performance

1 Year:-1.35%
6 Months:+13.30%
3 Months:+15.58%
1 Month:-6.83%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 64% of range
₹582.79 ₹898.60
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMAAbove
  • RSI (14)42.29 · Neutral
Price Performance
1M-6.83%
3M+15.58%
6M+13.30%
1Y-1.35%
Valuation vs Sector

P/E of 19.84 is below the sector median of 35.90 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Revenue declined at -1.1% CAGR over 5 years.
  • Earnings shrank at -34.7% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
19.84
Industry PE
35.90
Forward P/E est.
9.92
PEG Ratio
-
Book Value
₹686.04
Price to Book
1.15
P/S
1.24
EV/EBITDA
8.38
Dividend Yield
0.62%

Growth (CAGR)

Revenue 5Y
-1.05%
Profit 5Y
-34.71%
Revenue (YoY)
43.60%
Earnings (YoY)
303.10%

Profitability & Returns

ROCE
0.76%
ROE
-0.38%
ROA
-0.29%
Profit Margin
6.19%
Op Margin
8.24%
Gross Margin
65.76%
EPS (Latest Qtr)
₹-37.56
EPS (TTM)
₹39.53

Balance Sheet & Liquidity

Debt/Equity
0.08
Quick Ratio
2.74
Current Ratio
3.24
Debt
₹29.58 Cr
Total Assets
₹519.13 Cr
Current Assets
₹374.40 Cr
Working Capital
₹258.97 Cr

Ownership

Promoter Holding
64.04%
Chg in Prom Hold
-0.00%
FII / Inst Holding
1.61%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹447.61 Cr
Total Revenue (TTM)
₹364.37 Cr
EBITDA
₹26.86 Cr
Free Cash Flow
₹-36.77 Cr
Operating Cash Flow
₹-7.66 Cr
Shares Outstanding
₹57.07 L
Gross Margin
65.76%
Payout Ratio
12.65%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 ALBERTDAVD Albert David Limited NSEPHARMA 784.30 19.84 ₹447.61 Cr 0.62% 0.76% -0.38% -1.05% -34.71%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,758.00 34.88 ₹4.22 L Cr 0.91% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 9,162.00 83.32 ₹2.43 L Cr 0.32% 18.96% 15.32% 10.98% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,615.30 73.73 ₹1.76 L Cr 0.81% 9.05% 25.79% 13.27% 20.22%
5 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,135.00 25.30 ₹1.13 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
6 LENSKART Lenskart Solutions Limited NIFTY_MIDNSEPHARMA 634.25 165.17 ₹1.10 L Cr 0.00% 7.21% 5.65% 35.38% 66.99%
7 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 7,604.50 52.35 ₹1.09 L Cr 0.25% 19.20% 20.48% 14.85% 33.34%
8 LAURUSLABS Laurus Labs Limited NIFTY_MIDNSEPHARMA 2,002.50 98.99 ₹1.08 L Cr 0.12% 19.53% 16.77% 3.77% 4.00%
9 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,330.90 31.92 ₹1.08 L Cr 0.99% 14.86% 11.27% 7.23% 11.45%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -74.89 Cr70.57 Cr87.24 Cr89.93 Cr85.86 Cr
Cost of Revenue -29.33 Cr25.28 Cr30.65 Cr27.83 Cr30.10 Cr
Gross Profit -45.57 Cr45.29 Cr56.59 Cr62.09 Cr55.77 Cr
Operating Expenses -52.13 Cr58.33 Cr56.28 Cr53.69 Cr55.73 Cr
Operating Income --6.56 Cr-13.04 Cr31.24 L8.40 Cr3.37 L
EBITDA --9.86 Cr11.38 Cr39.68 L23.22 Cr-22.08 Cr
Interest Expense -13.15 L55.48 L75.07 L89.77 L42.91 L
Pretax Income --11.81 Cr8.44 Cr-2.58 Cr19.90 Cr-25.23 Cr
Tax Provision --1.48 Cr50.07 L71.96 L4.60 Cr-3.80 Cr
Net Income --10.33 Cr7.94 Cr-3.30 Cr15.30 Cr-21.43 Cr
Diluted EPS --18.1013.91-5.7926.81-37.56

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -340.01 Cr360.26 Cr343.25 Cr329.36 Cr
Cost of Revenue -125.68 Cr128.40 Cr118.28 Cr115.84 Cr
Gross Profit -214.33 Cr231.86 Cr224.96 Cr213.53 Cr
Operating Expenses -177.78 Cr190.81 Cr227.77 Cr213.40 Cr
Operating Income -36.54 Cr41.05 Cr-2.81 Cr12.85 L
EBITDA -59.62 Cr104.32 Cr32.49 Cr12.83 Cr
Interest Expense -34.00 L20.72 L29.64 L2.55 Cr
Pretax Income -50.74 Cr97.29 Cr25.23 Cr52.49 L
Tax Provision -14.56 Cr21.87 Cr8.03 Cr2.02 Cr
Net Income -36.17 Cr75.42 Cr17.20 Cr-1.49 Cr
Diluted EPS -63.39132.1530.14-2.62

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -423.39 Cr497.99 Cr511.42 Cr519.13 Cr
Current Assets -304.24 Cr371.63 Cr354.05 Cr374.40 Cr
Cash & Equivalents -1.45 Cr5.44 Cr41.73 L29.91 L
Inventory -50.68 Cr43.61 Cr63.90 Cr58.27 Cr
Receivables -30.33 Cr29.33 Cr27.37 Cr33.92 Cr
Total Liabilities -111.82 Cr115.01 Cr118.93 Cr127.60 Cr
Current Liabilities -98.94 Cr99.05 Cr104.18 Cr115.43 Cr
Long Term Debt -----
Total Debt -5.32 Cr3.32 Cr12.32 Cr29.58 Cr
Total Equity -311.57 Cr382.98 Cr392.48 Cr391.54 Cr
Shares Outstanding -57.07 L57.07 L57.07 L57.07 L

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -10.52 Cr45.50 Cr-28.44 Cr-7.66 Cr
Investing Cash Flow --5.00 Cr-33.25 Cr23.30 Cr-4.40 Cr
Financing Cash Flow --6.36 Cr-8.27 Cr11.03 L11.92 Cr
Capital Expenditure --5.24 Cr-10.87 Cr-14.86 Cr-29.11 Cr
Free Cash Flow -5.28 Cr34.63 Cr-43.29 Cr-36.77 Cr
Net Change in Cash --84.24 L3.98 Cr-5.02 Cr-13.67 L

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -63.0%64.4%65.5%64.8%
Operating Margin % -10.7%11.4%-0.8%0.0%
Net Margin % -10.6%20.9%5.0%-0.5%
ROE % -11.6%19.7%4.4%-0.4%
ROCE % -11.3%10.3%-0.7%0.0%

Shareholding Pattern

Insiders
64.04%
Institutions
1.61%
Public Float
4.48%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ALBERTDAVD

Google News Fri, 09 Oct 2026

Albert David (ALBERTDAVD.NS) Steadies Near ₹795 as Stock Consolidates Below ₹835 Resistance - Cup and Handle - https://www.siam.in/

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPX0ZfcXJXQk8zcDdESnQwUmlzeDR6SDF1ZDV6LWg4cWZjVlhmS2dGV1RIemxpbkpoU1hfUnN2YVBJbGkySmE5Vmo1NDMxVHVBSkIwMmNCSElFVTJDazBEUjVlU09Fb3dxQnZ0ZlN5LWVHTFFucEJPZEdSOXhqX045aWFUQlgtcGxCU3dhUX…

Google News hu, 15 Oct 2026

ALBERTDAVD Q2 2026 Earnings: Loss Per Share of ₹2.62 as Revenue Declines 4.04% YoY - Annual Report - https://www.siam.in/

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOWWdkM3g4M1dvZ1RFWHFZZi15Y0Q1N1pTdzVQU1dDaWJDQ0xseGFDNEFPSEV0WlJaeC1hbmNpSDNNZnN0T0xodzY0TFVwZGpFUnNQbUFxNmZoMmhkOUFmQXp4RDliamdELTM3Tms2LUxjc3hHYkdmMWtwN0hJVXFIb2NvUkV4Zl9PZnExaj…

Google News Fri, 05 Jun 2026

Albert David Share Price Target 2026: Rs 850 Analyst Forecast - Univest

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE44MURrUlFKYU9RWHBOa2YzdFpUN0sySlIwUFJ5dGZfQXZzSURIUHJrckxoczg1Uk95NWxva2hMVk9mQzVwVkVzTjhyNE9FcTlVSldFajBjMEZmalpVYXZFaFVmNVN2T0VhX3hxckZB?oc=5" target="_blank">Albert David Share …

Google News Fri, 20 Aug 2021

Albert David Limited (ALBERTDAVD.NS) company profile and facts - Yahoo Finance - Yahoo Finance Singapore

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE42blZGMFlRdF9NV0JQSVNZUlhnWmkwRVdwb0xyTTdDeGY2OWxDM20xVzRMNndYeXhUdWRFcVo4S1VTSE5ucTBXMl9fYTZJNnpJYlZhU0tUTkVwWVpvYlY5dHBWOWlmYnVk?oc=5" target="_blank">Albert David Limited (ALBER…

Google News ue, 22 Sep 2026

Albert (ALBERTDAVD.NS) Stock Trend: +0.85% Higher, ₹891.35 the Next Hurdle 2026-09-22 - ETF Flow - siam.in

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNY2dKekxWTktRb0V5Xzd1WC1maUl2RXVNd1RWOWdOVkN1SGJBRmRZaFNta2otTUtDTktlejlYWi1rRDVoWVdSaXNMZThad05ERUs5SDZQMF9YeHhfMTJya1lxbDN4d18zZE9RZnduekNZTXlxcm5CQXVFaUZ1LVdnZThIYWx0TnhNLW1zWU…

Google News Wed, 11 May 2022

Albert David Limited recommends dividend of Rs. 9 - EquityBulls

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOR2ZZT1JRRWZSVklQQnlIeXBIeXlEX2d5cklZbFFiMW45NXg0eUhjbVY2Si1KNHRGZGYwTjB1MXB6VGU0VnJKemdVdWJPWTNTU2JQYXBCRXVmdTNUS08ySG9BZndDb1FhdWJYWEQ5UkJZc2YyWkJsV3ZCeTk1RmxwWXNTQS1kM2lsLUM3TG…

ALBERTDAVD — Frequently Asked Questions

What is the current share price of Albert David Limited (ALBERTDAVD)?

As of 2026-10-24 04:55 IST, Albert David Limited (ALBERTDAVD) trades at ₹784.30 on NSE. Its 52-week range is ₹582.79 to ₹898.60.

What is the market capitalisation of ALBERTDAVD?

Albert David Limited (ALBERTDAVD) has a market capitalisation of ₹447.61 Cr on NSE.

What is the P/E ratio of ALBERTDAVD?

ALBERTDAVD trades at a trailing price-to-earnings (P/E) ratio of 19.84. The industry average P/E is 35.90. Its price-to-book (P/B) ratio is 1.15.

Does ALBERTDAVD pay a dividend?

Albert David Limited (ALBERTDAVD) currently offers a dividend yield of 0.62%.

What is the return on equity (ROE) of ALBERTDAVD?

ALBERTDAVD has a return on equity (ROE) of -0.38%. Its return on capital employed (ROCE) is 0.76%.

Is ALBERTDAVD a good stock to buy?

This page provides a data-driven analysis of Albert David Limited (ALBERTDAVD), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space